-
公开(公告)号:US20210324105A1
公开(公告)日:2021-10-21
申请号:US17149019
申请日:2021-01-14
Applicant: GENMAB A/S
Inventor: Bart DE GOEIJ , Patrick VAN BERKEL , Kristin STRUMANE , Aran Frank LABRIJN , Joost J. NEIJSSEN , Joyce I. MEESTERS , Paul PARREN , Janine SCHUURMAN
Abstract: Bispecific antibodies which comprise antigen-binding regions binding to two different epitopes of human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and methods of preparing and using the antibodies are also disclosed.
-
公开(公告)号:US20250066506A1
公开(公告)日:2025-02-27
申请号:US18596319
申请日:2024-03-05
Applicant: GENMAB A/S
Inventor: Bart DE GOEIJ , Patrick VAN BERKEL , Kristin STRUMANE , Aran Frank LABRIJN , Joost J. NEIJSSEN , Joyce I. MEESTERS , Paul PARREN , Janine SCHUURMAN
Abstract: Bispecific antibodies which comprise antigen-binding regions binding to two different epitopes of human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and methods of preparing and using the antibodies are also disclosed.
-
公开(公告)号:US20170369590A1
公开(公告)日:2017-12-28
申请号:US15599393
申请日:2017-05-18
Applicant: GENMAB A/S
Inventor: Bart DE GOEIJ , Patrick VAN BERKEL , Kristin STRUMANE , Aran Frank LABRIJN , Joost J. NEIJSSEN , Joyce I. MEESTERS , Paul PARREN , Janine SCHUURMAN
IPC: C07K16/32 , A61K45/06 , A61K47/68 , A61K39/395 , A61K39/00
CPC classification number: C07K16/32 , A61K39/395 , A61K45/06 , A61K47/6803 , A61K47/6849 , A61K47/6855 , A61K47/6879 , A61K2039/505 , C07K16/1063 , C07K16/2809 , C07K16/2863 , C07K16/2887 , C07K16/468 , C07K2317/21 , C07K2317/24 , C07K2317/30 , C07K2317/31 , C07K2317/33 , C07K2317/41 , C07K2317/526 , C07K2317/53 , C07K2317/55 , C07K2317/73 , C07K2317/732 , C07K2317/734 , C07K2317/77 , C07K2317/92 , C07K2317/94
Abstract: Bispecific antibodies which comprise antigen-binding regions binding to two different epitopes of human epidermal growth factor receptor 2 (HER2), and related antibody-based compositions and molecules, are disclosed. Pharmaceutical compositions comprising the antibodies and methods of preparing and using the antibodies are also disclosed.
-
-